Lenacapavir offers twice-yearly HIV prevention with near-complete protection in clinical trials. Clinical trials show ...

People with HIV face nearly three times the risk of subclinical obstructive coronary atherosclerosis, even with comparable cardiovascular risk profiles, new imaging data reveal.

Experts warn that the surge in HIV cases among Filipino youth is being driven by policy gaps, inadequate sex education and a ...

People living with HIV face unique oral health challenges that require special attention and care. The virus's impact on the ...

With Fiji in the midst of an HIV outbreak, UNAIDS warns that other Pacific Islands countries have all the risk factors of a ...

Vulvovaginal candidiasis (VVC) represents a universal health hazard that contributes to significant morbidity in HIV-positive women. Antifungal resistance is a worldwide increasing health problem that ...

Two red lines were all it took to confirm what 26-year-old Luke Galade (not his real name) had already prepared himself for.

Merck will share new scientific findings from its HIV clinical development programs, including Phase 2 data on the safety and pharmacokinetics of MK-8527, an investigational, novel nucleoside reverse ...

From age to previous exposure to radiation therapy, know the main causes that can trigger the development of sarcoma.

"There is now an urgent need for bolder and more realistic approaches to address HIV transmission among IPT students, similar ...

Individuals with IBD, especially CD, have an increased risk for myocardial infarction, ischemic heart disease, cerebrovascular accident, and major adverse cardiovascular events.